Literature DB >> 34517798

Advances in Biocatalytic Synthesis, Pharmacological Activities, Pharmaceutical Preparation and Metabolism of Ginsenoside Rh2.

Li Liu1, Huiyun Wang2, Xiaoyun Chai3, Qingguo Meng1, Sheng Jiang4, Fenglan Zhao1.   

Abstract

Ginsenoside Rh2 (3β-O-Glc-protopanaxadiol), a trace but characteristic pharmacological component of red ginseng, exhibited versatile pharmacological activities, such as antitumor effects, improved cardiac function and fibrosis, anti-inflammatory effects, antibiosis and excellent medicinal potential. In recent years, increased research has been performed on the biocatalytic synthesis of ginsenoside Rh2. In this paper, advances in the biocatalytic synthesis, pharmacological activities, pharmaceutical preparation and metabolism of ginsenoside Rh2 are reviewed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Ginsenoside Rh2; Panax notoginseng waste; biocatalytic synthesis; metabolism; pharmaceutical preparation; pharmacological activity

Mesh:

Substances:

Year:  2022        PMID: 34517798     DOI: 10.2174/1389557521666210913114631

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  1 in total

1.  Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway.

Authors:  Chen Chen; Heng Zhang; Siyi Hou; Yue Liu; Lu Ren; Miao Hao; Keyan Chen; Lingkang Li; Xintong Cai; Zisu Deng; Zhuang Liu; Ping Hou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-28       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.